Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators
about
Obatoclax, a BH3 Mimetic, Enhances Cisplatin-Induced Apoptosis and Decreases the Clonogenicity of Muscle Invasive Bladder Cancer Cells via Mechanisms That Involve the Inhibition of Pro-Survival Molecules as Well as Cell Cycle Regulators
description
im März 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 14 March 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2019
@uk
name
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@en
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@nl
type
label
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@en
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@nl
prefLabel
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@en
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@nl
P2093
P50
P356
P1476
Obatoclax, a BH3 Mimetic, Enha ...... Well as Cell Cycle Regulators
@en
P2093
George C Talbott
Thomas M Steele
P356
10.3390/IJMS20061285
P407
P577
2019-03-14T00:00:00Z